Form 4 for ASND Ascendis Pharma A/S
Accepted 2026-09-03 16:09:06 ET · period of report 2026-09-02 · accession 0001610717-26-000395 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-03 16:09 | 2026-09-02 | ASND | HOLTUG LARS | Dir | S - Sale | $264.13 | -236 | 4,000 | -6% | -$62.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-09-02 | S | D | 236 | $264.13 | 4,000 | D | — | — |